MedTrace Logo

Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants

NCT00288977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-03-16

No results posted yet for this study

Summary

Study hypothesis is that we can reproduce results of islet transplantation in type one diabetics in patients with a kidney transplant.

Conditions

Interventions

PROCEDURE

Islet Infusion

Sponsors & Collaborators

Principal Investigators

  • Martha Pavlakis, MD · Beth Israel Deaconess Medical Center, Joslin Diabetes Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288977 on ClinicalTrials.gov